Vascular Ehlers–Danlos Syndrome: A Good Experimental Model Is Needed for Development of Treatment Strategies
Authors:
- 7 July 2011
- book chapter
- Published by Springer Nature
- p. 241-251
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Causes and histopathology of ascending aortic disease in children and young adultsCardiovascular Pathology, 2011
- Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiencyEuropean Journal of Human Genetics, 2010
- TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportionsJournal of Clinical Investigation, 2010
- Pathophysiological Changes in Calf Muscle Predict Mobility Loss at 2-Year Follow-Up in Men and Women With Peripheral Arterial DiseaseCirculation, 2009
- Homozygosity for a null allele of COL3A1 results in recessive Ehlers–Danlos syndromeEuropean Journal of Human Genetics, 2009
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease PatientsCurrent Biology, 2009
- Allele‐specific silencing of the dominant disease allele in sialuria by RNA interferenceThe FASEB Journal, 2008
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Determinants of specific RNA interference-mediated silencing of human β-globin alleles differing by a single nucleotide polymorphismProceedings of the National Academy of Sciences, 2006
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004